Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Japan approves Solasia's Episil

Solasia Pharma K.K. (Tokyo:4597) said Japan's Ministry of Health, Labour and Welfare (MHLW) approved Episil (episil

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE